This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kashles, O
Right arrow Articles by Schlessinger, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kashles, O
Right arrow Articles by Schlessinger, J

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 March; 11(3): 1454-1463

A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization.

O Kashles, Y Yarden, R Fischer, A Ullrich and J Schlessinger

Department of Pharmacology, New York University Medical Center, New York 10016.

ABSTRACT

Recent studies provide evidence that defective receptors can function as a dominant negative mutation suppressing the action of wild-type receptors. This causes various diminished responses in cell culture and developmental disorders in murine embryogenesis. Here, we describe a model system and a potential mechanism underlying the dominant suppressing response caused by defective epidermal growth factor (EGF) receptors. We used cultured 3T3 cells coexpressing human wild-type receptors and an inactive deletion mutant lacking most of the cytoplasmic domain. When expressed alone, EGF was able to stimulate the dimerization of either wild-type or mutant receptors in living cells as revealed by chemical covalent cross-linking experiments. In response to EGF, heterodimers and homodimers of wild-type and mutant receptors were observed in cells coexpressing both receptor species. However, only homodimers of wild-type EGF receptors underwent EGF-induced tyrosine autophosphorylation in living cells. These results indicate that the integrity of both receptor moieties within receptor dimers is essential for kinase activation and autophosphorylation. Moreover, the presence of mutant receptors in cells expressing wild-type receptors diminished the number of high-affinity binding sites for EGF, reduced the rate of receptor endocytosis and degradation, and diminished biological signalling via EGF receptors. We propose that heterodimerization with defective EGF receptors functions as a dominant negative mutation suppressing the activation and response of normal receptors by formation of unproductive heterodimers.

Mol Cell Biol. 1991 March; 11(3): 1454-1463




This article has been cited by other articles:

  • Rajagopalan, V., Zucker, I. H., Jones, J. A., Carlson, M., Ma, Y. J. (2008). Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction. Am. J. Physiol. Heart Circ. Physiol. 295: H543-H554 [Abstract] [Full Text]  
  • Macdonald, J. L., Pike, L. J. (2008). Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc. Natl. Acad. Sci. USA 105: 112-117 [Abstract] [Full Text]  
  • Ozcan, F., Klein, P., Lemmon, M. A., Lax, I., Schlessinger, J. (2006). On the nature of low- and high-affinity EGF receptors on living cells. Proc. Natl. Acad. Sci. USA 103: 5735-5740 [Abstract] [Full Text]  
  • Chan, J. K., Pham, H., You, X. J., Cloven, N. G., Burger, R. A., Rose, G. S., Van Nostrand, K., Korc, M., DiSaia, P. J., Fan, H. (2005). Suppression of Ovarian Cancer Cell Tumorigenicity and Evasion of Cisplatin Resistance Using a Truncated Epidermal Growth Factor Receptor in a Rat Model. Cancer Res. 65: 3243-3248 [Abstract] [Full Text]  
  • Shen, X., Kramer, R. H. (2004). Adhesion-Mediated Squamous Cell Carcinoma Survival through Ligand-Independent Activation of Epidermal Growth Factor Receptor. Am. J. Pathol. 165: 1315-1329 [Abstract] [Full Text]  
  • Lammering, G., Hewit, T. H., Holmes, M., Valerie, K., Hawkins, W., Lin, P.-S., Mikkelsen, R. B., Schmidt-Ullrich, R. K. (2004). Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity. Clin. Cancer Res. 10: 6732-6743 [Abstract] [Full Text]  
  • Klein, P., Mattoon, D., Lemmon, M. A., Schlessinger, J. (2004). A structure-based model for ligand binding and dimerization of EGF receptors. Proc. Natl. Acad. Sci. USA 101: 929-934 [Abstract] [Full Text]  
  • Li, B., Yang, Z., Hou, J., McCracken, A., Jennings, M. A., Ma, M. Y. J. (2003). Compromised Reproductive Function in Adult Female Mice Selectively Expressing Mutant ErbB-1 Tyrosine Kinase Receptors in Astroglia. Mol. Endocrinol. 17: 2365-2376 [Abstract] [Full Text]  
  • Dievart, A., Dalal, M., Tax, F. E., Lacey, A. D., Huttly, A., Li, J., Clark, S. E. (2003). CLAVATA1 Dominant-Negative Alleles Reveal Functional Overlap between Multiple Receptor Kinases That Regulate Meristem and Organ Development. Plant Cell 15: 1198-1211 [Abstract] [Full Text]  
  • Yue, Y., Chen, Z.-Y., Gale, N. W., Blair-Flynn, J., Hu, T.-J., Yue, X., Cooper, M., Crockett, D. P., Yancopoulos, G. D., Tessarollo, L., Zhou, R. (2002). Mistargeting hippocampal axons by expression of a truncated Eph receptor. Proc. Natl. Acad. Sci. USA 99: 10777-10782 [Abstract] [Full Text]  
  • Casanova, M. L., Larcher, F., Casanova, B., Murillas, R., Fernandez-Acenero, M. J., Villanueva, C., Martinez-Palacio, J., Ullrich, A., Conti, C. J., Jorcano, J. L. (2002). A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis. Cancer Res. 62: 3402-3407 [Abstract] [Full Text]  
  • Guichard, A., Srinivasan, S., Zimm, G., Bier, E. (2002). A screen for dominant mutations applied to components in the Drosophila EGF-R pathway. Proc. Natl. Acad. Sci. USA 99: 3752-3757 [Abstract] [Full Text]  
  • Freywald, A., Sharfe, N., Roifman, C. M. (2002). The Kinase-null EphB6 Receptor Undergoes Transphosphorylation in a Complex with EphB1. J. Biol. Chem. 277: 3823-3828 [Abstract] [Full Text]  
  • Lammering, G., Hewit, T. H., Hawkins, W. T., Contessa, J. N., Reardon, D. B., Lin, P.-S., Valerie, K., Dent, P., Mikkelsen, R. B., Schmidt-Ullrich, R. K. (2001). Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization. JNCI J Natl Cancer Inst 93: 921-929 [Abstract] [Full Text]  
  • Lammering, G., Valerie, K., Lin, P.-S., Mikkelsen, R. B., Contessa, J. N., Feden, J. P., Farnsworth, J., Dent, P., Schmidt-Ullrich, R. K. (2001). Radiosensitization of Malignant Glioma Cells through Overexpression of Dominant-Negative Epidermal Growth Factor Receptor. Clin. Cancer Res. 7: 682-690 [Abstract] [Full Text]  
  • Verveer, P. J., Wouters, F. S., Reynolds, A. R., Bastiaens, P. I. H. (2000). Quantitative Imaging of Lateral ErbB1 Receptor Signal Propagation in the Plasma Membrane. Science 290: 1567-1570 [Abstract] [Full Text]  
  • Grosse, R., Roelle, S., Herrlich, A., Hohn, J., Gudermann, T. (2000). Epidermal Growth Factor Receptor Tyrosine Kinase Mediates Ras Activation by Gonadotropin-releasing Hormone. J. Biol. Chem. 275: 12251-12260 [Abstract] [Full Text]  
  • Ram, T. G., Schelling, M. E., Hosick, H. L. (2000). Blocking HER-2/HER-3 Function with a Dominant Negative Form of HER-3 in Cells Stimulated by Heregulin and in Breast Cancer Cells with HER-2 Gene Amplification. Cell Growth Differ. 11: 173-183 [Abstract] [Full Text]  
  • Saxon, M. L., Lee, D. C. (1999). Mutagenesis Reveals a Role for Epidermal Growth Factor Receptor Extracellular Subdomain IV in Ligand Binding. J. Biol. Chem. 274: 28356-28362 [Abstract] [Full Text]  
  • Maeda, T., Yamada, Y., Moriuchi, R., Sugahara, K., Tsuruda, K., Joh, T., Atogami, S., Tsukasaki, K., Tomonaga, M., Kamihira, S. (1999). Fas Gene Mutation in the Progression of Adult T Cell Leukemia. JEM 189: 1063-1071 [Abstract] [Full Text]  
  • Qi, Z., Atsuchi, N., Ooshima, A., Takeshita, A., Ueno, H. (1999). Blockade of type beta  transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc. Natl. Acad. Sci. USA 96: 2345-2349 [Abstract] [Full Text]  
  • Contessa, J. N., Reardon, D. B., Todd, D., Dent, P., Mikkelsen, R. B., Valerie, K., Bowers, G. D., Schmidt-Ullrich, R. K. (1999). The Inducible Expression of Dominant-Negative Epidermal Growth Factor Receptor-CD533 Results in Radiosensitization of Human Mammary Carcinoma Cells. Clin. Cancer Res. 5: 405-411 [Abstract] [Full Text]  
  • Guichard, A, Biehs, B, Sturtevant, M., Wickline, L, Chacko, J, Howard, K, Bier, E (1999). rhomboid and Star interact synergistically to promote EGFR/MAPK signaling during Drosophila wing vein development. Development 126: 2663-2676 [Abstract]  
  • Goldkorn, T., Balaban, N., Matsukuma, K., Chea, V., Gould, R., Last, J., Chan, C., Chavez, C. (1998). EGF-Receptor Phosphorylation and Signaling Are Targeted by H2O2 Redox Stress. Am. J. Respir. Cell Mol. Bio. 19: 786-798 [Abstract] [Full Text]  
  • Dosil, M., Giot, L., Davis, C., Konopka, J. B. (1998). Dominant-Negative Mutations in the G-Protein-Coupled alpha -Factor Receptor Map to the Extracellular Ends of the Transmembrane Segments. Mol. Cell. Biol. 18: 5981-5991 [Abstract] [Full Text]  
  • Herrlich, A., Daub, H., Knebel, A., Herrlich, P., Ullrich, A., Schultz, G., Gudermann, T. (1998). Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc. Natl. Acad. Sci. USA 95: 8985-8990 [Abstract] [Full Text]  
  • Dever, T. E., Sripriya, R., McLachlin, J. R., Lu, J., Fabian, J. R., Kimball, S. R., Miller, L. K. (1998). Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2alpha kinase homolog. Proc. Natl. Acad. Sci. USA 95: 4164-4169 [Abstract] [Full Text]  
  • Zhang, J, Carthew, R. (1998). Interactions between Wingless and DFz2 during Drosophila wing development. Development 125: 3075-3085 [Abstract]  
  • Xie, W., Paterson, A. J., Chin, E., Nabell, L. M., Kudlow, J. E. (1997). Targeted Expression of a Dominant Negative Epidermal Growth Factor Receptor in the Mammary Gland of Transgenic Mice Inhibits Pubertal Mammary Duct Development. Mol. Endocrinol. 11: 1766-1781 [Abstract] [Full Text]  
  • DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F., Kadin, M. E. (1997). Loss of functional cell surface transforming growth factor beta  (TGF-beta ) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 94: 5877-5881 [Abstract] [Full Text]  
  • O'Rourke, D. M., Qian, X., Zhang, H.-T., Davis, J. G., Nute, E., Meinkoth, J., Greene, M. I. (1997). Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains. Proc. Natl. Acad. Sci. USA 94: 3250-3255 [Abstract] [Full Text]  
  • Jackson, D, Bresnick, J, Rosewell, I, Crafton, T, Poulsom, R, Stamp, G, Dickson, C (1997). Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. J. Cell Sci. 110: 1261-1268 [Abstract]  
  • Yamamoto, H., Ueno, H., Ooshima, A., Takeshita, A. (1996). Adenovirus-mediated Transfer of a Truncated Transforming Growth Factor-beta (TGF-beta ) Type II Receptor Completely and Specifically Abolishes Diverse Signaling by TGF-beta in Vascular Wall Cells in Primary Culture. J. Biol. Chem. 271: 16253-16259 [Abstract] [Full Text]  
  • Wu, J., Adamson, E. (1996). Kinase-negative mutant epidermal growth factor receptor (EGFR) expression during embryonal stem cell differentiation favours EGFR-independent lineages. Development 122: 3331-3342 [Abstract]  
  • Chang, P.-Y., Goodyear, L. J., Benecke, H., Markuns, J. S., Moller, D. E. (1995). Impaired Insulin Signaling in Skeletal Muscles from Transgenic Mice Expressing Kinase-deficient Insulin Receptors. J. Biol. Chem. 270: 12593-12600 [Abstract] [Full Text]  
  • Chen, R.-H., Moses, H. L., Maruoka, E. M., Derynck, R., Kawabata, M. (1995). Phosphorylation-dependent Interaction of the Cytoplasmic Domains of the Type I and Type II Transforming Growth Factor-[IMAGE] Receptors. J. Biol. Chem. 270: 12235-12241 [Abstract] [Full Text]  
  • Brand, T., Schneider, M. D. (1995). Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription. J. Biol. Chem. 270: 8274-8284 [Abstract] [Full Text]  
  • Taylor, I. C. A., Roy, S., Yaswen, P., Stampfer, M. R., Varmus, H. E. (1995). Mouse Mammary Tumors Express Elevated Levels of RNA Encoding the Murine Homolog of SKY, a Putative Receptor Tyrosine Kinase. J. Biol. Chem. 270: 6872-6880 [Abstract] [Full Text]  
  • Chantry, A., Chantry, A. (1995). The Kinase Domain and Membrane Localization Determine Intracellular Interactions between Epidermal Growth Factor Receptors. J. Biol. Chem. 270: 3068-3073 [Abstract] [Full Text]  
  • Ferrari, G., Anderson, B. L., Stephens, R. M., Kaplan, D. R., Greene, L. A. (1995). Prevention of Apoptotic Neuronal Death by G[IMAGE] Ganglioside. J. Biol. Chem. 270: 3074-3080 [Abstract] [Full Text]  
  • Thompson, D. K., Garbers, D. L. (1995). Dominant Negative Mutations of the Guanylyl Cyclase-A Receptor. J. Biol. Chem. 270: 425-430 [Abstract] [Full Text]  
  • Chen, R., Ebner, R, Derynck, R (1993). Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science 260: 1335-1338 [Abstract]  
  • Stoddard, B.L., Biemann, H.-P., Koshland, D.E. Jr. (1992). Receptors and Transmembrane Signaling. Cold Spring Harb Symp Quant Biol 57: 1-15 [Abstract]  
  • Milligan, D., Koshland, D. Jr (1991). Intrasubunit signal transduction by the aspartate chemoreceptor. Science 254: 1651-1654 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»